Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study
Open Access
- 7 November 2016
- journal article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 66 (653) , e880-e886
Abstract
Background Colorectal cancer is the third most common cancer worldwide and second most common in Europe. Despite screening, it is often diagnosed at an unfavourable stage. Aim To identify and quantify features of non-metastatic colorectal cancer in primary care to enable earlier diagnosis by GPs. Design and setting A case-control study was conducted using diagnostic codes from national and regional healthcare databases in Sweden. Method A total of 542 patients diagnosed with non-metastatic colorectal cancer in 2011 and 2139 matched controls were selected from the Swedish Cancer Register (SCR) and a regional healthcare database respectively. All diagnostic codes (according to ICD-10) from primary care consultations registered the year before the date of cancer diagnosis (according to the SCR) were collected from the regional database. Odds ratios were calculated for variables independently associated with non-metastatic colorectal cancer using multivariable conditional logistic regressions. Positive predictive values (PPVs) of these variables were calculated, both individually and in combination with each other. Results Five features were associated with colorectal cancer before diagnosis: bleeding, including rectal bleeding, melaena, and gastrointestinal bleeding (PPV 3.9%, 95% confidence interval [CI] = 2.3 to 6.3); anaemia (PPV 1.4%, 95% CI = 1.1 to 1.8); change in bowel habit (PPV 1.1%, 95% CI = 0.9 to 1.5; abdominal pain (PPV 0.9%, 95% CI = 0.7 to 1.1); and weight loss (PPV 1.0%, 95% CI = 0.3 to 3.0); all P-value <0.05. The combination of bleeding and change in bowel habit had a PPV of 13.7% (95% CI = 2.1 to 54.4); for bleeding combined with abdominal pain this was 12.2% (95% CI = 1.8 to 51.2). A risk assessment tool for non-metastatic colorectal cancer was designed. Conclusion Bleeding combined with either diarrhoea, constipation, change in bowel habit, or abdominal pain are the most powerful predictors of non-metastatic colorectal cancer and should result in prompt referral for colorectal investigation.Keywords
This publication has 26 references indexed in Scilit:
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewBritish Journal of Cancer, 2015
- Rethinking diagnostic delay in cancer: how difficult is the diagnosis?BMJ, 2014
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary careEuropean Journal of Cancer, 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasetsJournal of Clinical Epidemiology, 2012
- Why so late?!—delay in treatment of colorectal cancer is socially determinedLangenbeck's Archives of Surgery, 2010
- Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancersBritish Journal of Cancer, 2009
- General practitioners' role in cancer care: a French-Norwegian studyBMC Research Notes, 2009
- Clinical features of colorectal cancer before diagnosis: a population-based case–control studyBritish Journal of Cancer, 2005